
Through this approach, says Martin, NDA Partners “utilise the very best talent available anywhere in the world, delivering extraordinary value to its clients.”
The company helps early-stage biopharma and device companies identify the most appropriate regulatory pathways, prepare effective pre-clinical and clinical development plans, design efficient and informative study protocols, assess data, evaluate readiness for regulatory submissions, prepare for meetings with regulatory agencies and submit regulatory applications.
At Mega Pharmaceutical, quality management is our foremost concern because the company believes in building of quality right from the selection of raw material through the whole manufacturing process, till the end product. The GMP (Good Manufacturing Practice) reflects our interest in production of quality medicines. With edge of Mega Pharmaceutical system from our highly skilled work force and professional management backed by ongoing integrated human resource training and development program.
At Mega Pharmaceutical, quality management is our foremost concern because the company believes in building of quality right from the selection of raw material through the whole manufacturing process, till the end product.